- Home
- VMD vs OVID Comparison
VMD vs OVID Comparison
Compare VMD & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VMD | OVID |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.3M | 365.5M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VMD | OVID |
|---|---|---|
| Price | $9.24 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.20 |
| AVG Volume (30 Days) | 341.8K | ★ 3.3M |
| Earning Date | 03-04-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.14 | 3.90 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $270,280,000.00 | $7,252,000.00 |
| Revenue This Year | $17.88 | N/A |
| Revenue Next Year | $14.98 | N/A |
| P/E Ratio | $24.92 | ★ N/A |
| Revenue Growth | 20.52 | ★ 1181.27 |
| 52 Week Low | $5.93 | $0.24 |
| 52 Week High | $10.06 | $2.72 |
Technical Indicators
Market Signals| Indicator | VMD | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 62.87 |
| Support Level | $7.93 | $1.31 |
| Resistance Level | $10.06 | $2.38 |
| Average True Range (ATR) | 0.43 | 0.20 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 42.71 | 54.49 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.